tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
US Market

Syros Pharmaceuticals (SYRS) Income Statement

Compare
1,046 Followers

Syros Pharmaceuticals Income Statement

Last quarter (Q3 2024), Syros Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Syros Pharmaceuticals's net income was $-6.40M. See Syros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.94M$ 14.88M$ 23.49M$ 15.09M$ 1.98M
Gross Profit
$ 7.68M$ 11.91M$ 23.49M$ 15.09M$ 1.98M
Operating Expenses
$ 138.92M$ 141.24M$ 122.91M$ 97.39M$ 79.72M
Depreciation and Amortization
$ 2.25M$ 2.97M$ 3.02M$ 3.04M$ 2.72M
EBITDA
$ -157.19M$ -87.55M$ -79.63M$ -79.21M$ -72.72M
Operating Income
$ -128.99M$ -135.87M$ -99.42M$ -82.30M$ -77.74M
Other Income/Expenses
$ -35.59M$ 41.22M$ 12.86M$ -1.74M$ 2.30M
Pretax Income
$ -164.57M$ -94.65M$ -86.56M$ -84.04M$ -75.44M
Net Income
$ -164.57M$ -49.30M$ -90.47M$ -85.83M$ -75.44M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.81$ -3.90$ -14.47$ -18.64$ -18.76
Diluted EPS
$ -5.81$ -3.90$ -14.47$ -18.64$ -18.76
Weighted Average Shares Outstanding
28.33M 12.63M 6.25M 4.61M 4.02M
Weighted Average Shares Outstanding (Diluted)
28.33M 12.63M 6.25M 4.61M 4.02M
Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis